Related Experiment Video
Updated: Jun 8, 2026
06:58
Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
Published on: June 25, 2016
[Antiepileptic drug-induced encephalopathy]
1Neurologische Klinik und Poliklinik, Julius-Maximilians-Universität Würzburg, Würzburg. Hansen_N@klinik.uniwuerzburg.de
Fortschritte Der Neurologie-Psychiatrie
|October 8, 2010
Summary
Antiepileptic drug-induced encephalopathy (ADE) presents with confusion and neurological changes, even with normal drug levels. Immediate discontinuation of the offending antiepileptic drug is the primary treatment for this neurological condition.
Area of Science:
- Neurology
- Clinical Pharmacology
Context:
- Antiepileptic drug-induced encephalopathy (ADE) is a recognized adverse effect of antiepileptic drug (AED) therapy.
- Clinical manifestations include confusion, reduced vigilance, neurological deficits, and increased seizure frequency.
- Electroencephalogram findings may show general slowing or epileptic discharges.
Purpose:
- To describe the clinical features, diagnostic characteristics, and potential pathogenic mechanisms of antiepileptic drug-induced encephalopathy (ADE).
- To highlight that ADE can occur even with non-toxic blood levels of antiepileptic drugs.
Summary:
- ADE has been reported with various AEDs including phenytoin, carbamazepine, valproic acid, vigabatrin, lamotrigine, and topiramate.
- Potential mechanisms include hyperammonemia, direct effects on cerebral receptors, drug interactions, and metabolic disturbances.
- Characteristic findings include normal therapeutic drug levels, distinguishing ADE from overdose.
Impact:
- Emphasizes the importance of considering ADE in patients presenting with new-onset neurological symptoms during AED therapy.
- The primary therapeutic intervention for ADE is the immediate discontinuation of the causative antiepileptic drug.
- Understanding ADE mechanisms can guide future drug development and patient management strategies.
Related Concept Videos
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...